Актуальные хирургические методы лечения гиперплазии предстательной железы

Актуальные хирургические методы лечения гиперплазии предстательной железы

Автор: Ширяев А.А., Говоров А.В., Васильев А.О., Соловьев В.В., Пушкарь Д.Ю.

Журнал: Московский хирургический журнал @mossj

Статья в выпуске: S1, 2022 года.

Бесплатный доступ

Доброкачественная гиперплазия предстательной железы (ДГПЖ) является одним из наиболее распространенных состояний, поражающих мужчин среднего возраста. До 15-25% мужчин в возрасте от 50 до 65 лет имеют симптомы нижних мочевыводящих путей (СНМП), которые обычно связаны с доброкачественным разрастанием ткани предстательной железы. Хотя СНМП часто ассоциируются с ДГПЖ, СНМП также могут быть вызваны различными не связанными синдромами, такими как сердечная недостаточность, инфекции мочевыводящих путей и сахарный диабет. В данной статье проведен обзор публикаций по теме современных и актуальных методов лечения гиперплазии простаты, а также проведен анализ их эффективности и безопасности. Появление большого количества хирургических методов лечения гиперплазии простаты предопределило поиск наиболее эффективных и безопасных из них. Данные проведенного нами проспективного, сравнительного исследования на кафедре урологии МГМСУ имени А.И. Евдокимова на базе ГКБ имени С.И. Спасокукоцкого позволили резюмировать, что все представленные в данной статье методы хирургического лечения ДГПЖ продемонстрировали свою эффективность, но, при этом, только методики тулиевой энуклеации и ТУРП позволяют провести операцию эндоскопически, сохраняя целостность кожных покровов, безопасно и радикально.

Еще

Гиперплазия, предстательная железы, хирургические методы лечения, трансуретральная резекция

Короткий адрес: https://sciup.org/142236598

IDR: 142236598   |   DOI: 10.17238/2072-3180-2022-71-78

Список литературы Актуальные хирургические методы лечения гиперплазии предстательной железы

  • Mahon J., McVary K. New alternative treatments for lower urinary tract symptoms secondary to benign prostatic hyperplasia. In: Minimally Invasive Urology: An Essential Clinical Guide to Endourology, Laparoscopy, LESS and Robotics, 2nd edn, Best SL, Nakada SY (Eds): Springer, 2020.
  • Foster H., Dahm P., Kohler T. Surgical Management of Lower Uri¬nary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019. J Urol, 2019, № 202, pp. 592-598. https://doi.org/10.1097/JU.0000000000000319
  • Wei J., Calhoun E., Jacobsen S. Urologic diseases in America project: benign prostatic hyperplasia. J Urol, 2005, № 173, pp. 1256-1261. https://doi.org/10.1097/01.ju.0000155709.37840.fe
  • Welliver C., Feinstein L., Ward J. Trends in Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia, 2004 to 2013: the Urologic Diseases in America Project. J Urol, 2020, № 203, pp. 171-178. https://doi.org/10.1097/JU.0000000000000499
  • McVary K., Roehrborn C., Avins A.L. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol, 2011, № 185, pр. 1793-1803. https://doi.org/10.1016/j.juro.2011.01.074
  • Jacobsen S., Jacobson D., Girman C. Natural history of prostatism: risk factors for acute urinary retention. J Urol, 1997, № 158, pp. 481-487. https://doi.org/10.1016/s0022-5347(01)64508-7
  • Lightner D., Wymer K., Sanchez J., Kavoussi L. Best Practice State¬ment on Urologic Procedures and Antimicrobial Prophylaxis. J Urol, 2020, № 203, pp. 351-356. https://doi.org/10.1097/JU.0000000000000509
  • Forrest J., Clemens J., Finamore P. AUA Best Practice Statement for the prevention of deep vein thrombosis in patients undergoing urolog¬ic surgery. J Urol, 2009, № 181, pp. 1170-1177. https://doi.org/10.1016/j.juro.2008.12.027
  • Michalski W., Poniatowska G., Jonska-Gmyrek J. Venous thrombo¬prophylaxis in urological cancer surgery. Med Oncol, 2019, № 37, pp. 11. https://doi.org/10.1007/s12032-019-1331-8
  • Borth C., Nickel J. Management of spontaneous prostate related bleeding. AUA: Update Series, 2006
  • Optimizing Outcomes in Urologic Surgery. American Urological As¬sociation: White Paper, 2018.
  • Fwu C., Eggers P., Kirkali Z. Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associ¬ated with long-term treatment with doxazosin, finasteride and combined therapy. J Urol., 2014, № 191, pp. 1828-1834. https://doi.org/10.1016/j.juro.2013.12.014
  • American Urological Association (AUA). Guideline. Benign Pros¬tatic Hyperplasia: Surgical Management of Benign Prostatic Hyperplasia/ Lower Urinary Tract Symptoms, 2019.
  • Issa M. Technological advances in transurethral resection of the prostate: bipolar versus monopolar TURP. J Endourol, 2008, № 22, pp. 1589-1595. https://doi.org/10.1089/end.2008.0192
  • Omar M., Lam T., Alexander C. Systematic review and meta-anal¬ysis of the clinical effectiveness of bipolar compared with monopolar trans¬urethral resection of the prostate (TURP). BJU Int, 2014, № 113, pp. 24-35. https://doi.org/10.1111/bju.12281
  • Cornu J., Ahyai S., Bachmann A. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Result¬ing from Benign Prostatic Obstruction: An Update. Eur Urol., 2015, № 67, pp. 1066-1096. https://doi.org/10.1016/j.eururo.2014.06.017
  • Nuhoğlu B., Balci M., Aydin M. The role of bipolar transurethral vaporization in the management of benign prostatic hyperplasia. Urol Int., 2011, № 87, pp. 400-404. https://doi.org/10.1159/000329797
  • Geavlete B., Georgescu D., Multescu R. Bipolar plasma vaporization vs monopolar and bipolar TURP-A prospective, randomized, long-term comparison. Urology, 2011, № 78, pp. 930-935. https://doi.org/10.1016/j.urology.2011.03.072
  • Lourenco T., Shaw M., Fraser C. The clinical effectiveness of trans¬urethral incision of the prostate: a systematic review of randomised con¬trolled trials. World J Urol, 2010, № 28, pp. 23-32. https://doi.org/10.1007/s00345-009-0496-8
  • Reich O., Gratzke C., Stief C. Techniques and long-term results of surgical procedures for BPH. Eur Urol, 2006, № 49, pp. 970-978. https://doi.org/10.1016/j.eururo.2005.12.072
  • Lee D., Rieken M., Halpern J. Laser Vaporization of the Prostate With the 180-W XPS-Greenlight Laser in Patients with Ongoing Platelet Aggregation Inhibition and Oral Anticoagulation. Urology, 2016, № 91, pp. 167-173. https://doi.org/10.1016/j.urology.2016.01.021
  • Brassetti A., Nunzio C., Delongchamps N. Green light vaporization of the prostate: is it an adult technique? Minerva Urol Nefrol, 2017, № 69, pp. 109-118. https://doi.org/10.23736/S0393-2249.16.02791-0
  • Bachmann A., Tubaro A., Barber N. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and ef¬ficacy results of a European Multicentre Randomised Trial--the GO¬LIATH study. Eur Urol., 2014, № 65, 31-42. https://doi.org/10.1016/j.eururo.2013.10.040
  • Thomas J., Tubaro A., Barber N. A Multicenter Randomized Non¬inferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study. Eur Urol., 2016, № 69, pp. 94-102. https://doi.org/10.1016/j.euru¬ro.2015.07.054
  • Bachmann A., Tubaro A., Barber N. A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GO¬LIATH study. J Urol., 2015, № 193, 570-578. https://doi.org/10.1016/j.juro.2014.09.001
  • Kuntz R.M., Lehrich K., Ahyai S.A. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol., 2008, № 53, pp. 160-166. https://doi.org/10.1016/j.eururo.2007.08.036
  • Kuntz R.M, Ahyai S., Lehrich K., Fayad A. Transurethral hol¬mium laser enucleation of the prostate versus transurethral electrocau¬tery resection of the prostate: a randomized prospective trial in 200 pa¬tients. J Urol., 2004, № 172, pp. 1012-1016. https://doi.org/10.1097/01.ju.0000136218.11998.9e
  • Foster H.E., Barry M.J., Dahm P. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline. J Urol., 2018, № 200, pp. 612-619. https://doi.org/10.1016/j.juro.2018.05.048
  • Zhong J., Feng Z., Peng Y., Liang H. A Systematic Review and Me¬ta-analysis of Efficacy and Safety Following Holmium Laser Enucleation of Prostate and Transurethral Resection of Prostate for Benign Prostatic Hy¬perplasia. Urology, 2019, № 131, pp. 14-20. https://doi.org/10.1016/j.urol¬ogy.2019.03.034
  • Hashim H., Worthington J., Abrams P. Thulium laser transure¬thral vaporesection of the prostate versus transurethral resection of the prostate for men with lower urinary tract symptoms or urinary retention (UNBLOCS): a randomised controlled trial. Lancet, 2020, 396, pp. 50-61. https://doi.org/10.1016/S0140-6736(20)30537-7
  • Gilling P., Anderson P., Tan A. Aquablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: 1-Year Results. J Urol., 2017, № 197, pp. 1565-1572. https://doi.org/10.1016/j.juro.2017.01.056.
  • Gilling P.J., Barber N., Bidair M. Randomized Controlled Trial of Aquablation versus Transurethral Resection of the Prostate in Benign Pros¬tatic Hyperplasia: One-year Outcomes. Urology, 2019, № 125, pp. 169-173. https://doi.org/10.1016/j.urology.2018.12.002
  • Gilling P., Barber N., Bidair M. WATER: A Double-Blind, Ran¬domized, Controlled Trial of Aquablation vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia. J Urol., 2018, № 199, pp. 1252- 1261. https://doi.org/10.1016/j.juro.2017.12.065
  • Hwang E.C., Jung J.H., Borofsky M. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign pros¬tatic hyperplasia. Cochrane Database Syst Rev., 2019, № 2, рр. CD013143. https://doi.org/10.1002/14651858.CD013143.pub2
  • Hoffman R.M., Monga M., Elliott S.P. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database Syst Rev, 2012, рр. CD004135. https://doi.org/10.1002/14651858.CD004135.pub3
  • Schelin S., Geertsen U., Walter S. Feedback microwave thermo¬therapy versus TURP/prostate enucleation surgery in patients with benign prostatic hyperplasia and persistent urinary retention: a prospective, ran¬domized, controlled, multicenter study. Urology, 2006, № 68, pp. 795-799. https://doi.org/10.1016/j.urology.2006.05.020
  • Wagrell L., Schelin S., Nordling J. Feedback microwave thermo¬therapy versus TURP for clinical BPH--a randomized controlled multi¬center study. Urology, 2002, № 60, pp. 292-299. https://doi.org/10.1016/s0090-4295(02)01740-5
  • Mattiasson A., Wagrell L., Schelin S. Five-year follow-up of feed¬back microwave thermotherapy versus TURP for clinical BPH: a prospec¬tive randomized multicenter study. Urology, 2007, № 69, pp. 91-96. https://doi.org/10.1016/j.urology.2006.08.1115
  • Zhang B., Wu G., Chen C. Combination of channel-TURP and ILC versus standard TURP or ILC for elderly with benign prostatic hyperplasia: a randomized prospective trial. Urol Int., 2011, № 87, pp. 392-399. https://doi.org/10.1159/000331500
  • Geavlete B., Bulai C., Ene C. Bipolar vaporization, resection, and enucleation versus open prostatectomy: optimal treatment alternatives in large prostate cases? J Endourol., 2015, № 29, pp. 323-331. https://doi.org/10.1089/end.2014.0493
  • Simforoosh N., Abdi H., Kashi A. Open prostatectomy versus transurethral resection of the prostate, where are we standing in the new era? A randomized controlled trial. Urol J, 2010, № 7, pp. 262-269.
  • Xie J., Tan Y., Wang F.L. Extraperitoneal laparoscopic adenomec¬tomy (Madigan) versus bipolar transurethral resection of the prostate for benign prostatic hyperplasia greater than 80 ml: complications and func¬tional outcomes after 3-year follow-up. J Endourol., 2014, № 28, pp. 353- 359. https://doi.org/10.1089/end.2013.0374
Еще
Статья научная
SciUp 2024 © 2024 ©